Clinical efficacy and safety of methotrexate versus hydroxychloroquine in preventing lichen planopilaris progress: A randomized clinical trial

International Journal of Preventive Medicine

Volumn 8, Issue , 2017, Pages

  Naeini, Farahnaz Fatemi ^a   Saber, Mina ^a   Asilian, Ali ^a   Hosseini, Sayed Mohsen ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hydroxychloroquine; Lichen planopilaris; Methotrexate

Indexed keywords

CHLOROQUINE; CORTICOSTEROID; CYCLOSPORIN; ETRETIN; HYDROXYCHLOROQUINE; ISOTRETINOIN; LIVER ENZYME; METHOTREXATE; MYCOPHENOLATE MOFETIL; PIOGLITAZONE;

ADULT; ADVERSE DRUG REACTION; ALOPECIA; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DARIER DISEASE; DERMATITIS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; LICHEN PLANOPILARIS; LICHEN PLANOPILARIS ACTIVITY INDEX; MALE; PERIFOLLICULAR ERYTHEMA; PERIFOLLICULAR SCALING; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 85020820937     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: 10.4103/ijpvm.IJPVM_156_17     Document Type: Article

References (25)

1. Olsen EA. Female pattern hair loss and its relationship to permanent/cicatricial alopecia: A new perspective. J Investig Dermatol Symp Proc 2005;10:217-21.
2. Ochoa BE, King LE Jr., Price VH. Lichen planopilaris: Annual incidence in four hair referral centers in the United States. J Am Acad Dermatol 2008;58:352-3.
3. Assouly P, Reygagne P. Lichen planopilaris: Update on diagnosis and treatment. Semin Cutan Med Surg 2009;28:3-10.
4. Kang H, Alzolibani AA, Otberg N, Shapiro J. Lichen planopilaris. Dermatol Ther 2008;21:249-56.
5. Chiang YZ, Bundy C, Griffiths CE, Paus R, Harries MJ. The role of beliefs: Lessons from a pilot study on illness perception, psychological distress and quality of life in patients with primary cicatricial alopecia. Br J Dermatol 2015;172:130-7.
6. Manousaridis I, Manousaridis K, Peitsch WK, Schneider SW. Individualizing treatment and choice of medication in lichen planus: A step by step approach. J Dtsch Dermatol Ges 2013;11:981-91.
7. Baibergenova A, Donovan J. Lichen planopilaris: Update on pathogenesis and treatment. Skinmed 2013;11:161-5.
8. Chiang C, Sah D, Cho BK, Ochoa BE, Price VH. Hydroxychloroquine and lichen planopilaris: Efficacy and introduction of lichen planopilaris activity index scoring system. J Am Acad Dermatol 2010;62:387-92.
9. Lajevardi V, Ghodsi SZ, Goodarzi A, Hejazi P, Azizpour A, Beygi S. Comparison of systemic mycophenolate mofetil with topical clobetasol in lichen planopilaris: A parallel-group, assessor-and analyst-blinded, randomized controlled trial. Am J Clin Dermatol 2015;16:303-11.
10. Tursen U, Api H, Kaya T, Ikizoglu G. Treatment of lichen planopilaris with mycophenolate mofetil. Dermatol Online J 2004;10:24.
11. Mirmirani P, Willey A, Price VH. Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol 2003;49:667-71.
12. Kreutzer K, Effendy I. Therapy-resistant folliculitis decalvans and lichen planopilaris successfully treated with adalimumab. J Dtsch Dermatol Ges 2014;12:74-6.
13. Spano F, Donovan JC. Efficacy of oral retinoids in treatment-resistant lichen planopilaris. J Am Acad Dermatol 2014;71:1016-8.
14. George SJ, Hsu S. Lichen planopilaris treated with thalidomide. J Am Acad Dermatol 2001;45:965-6.
15. Harries MJ, Messenger A. Treatment of frontal fibrosing alopecia and lichen planopilaris. J Eur Acad Dermatol Venereol 2014;28:1404-5.
16. Lajevardi V, Ghodsi SZ, Hallaji Z, Shafiei Z, Aghazadeh N, Akbari Z. Treatment of erosive oral lichen planus with methotrexate. J Dtsch Dermatol Ges 2016;14:286-93.
17. Jang N, Fischer G. Treatment of erosive vulvovaginal lichen planus with methotrexate. Australas J Dermatol 2008;49:216-9.
18. Nylander Lundqvist E, Wahlin YB, Hofer PA. Methotrexate supplemented with steroid ointments for the treatment of severe erosive lichen ruber. Acta Derm Venereol 2002;82:63-4.
19. Hazra SC, Choudhury AM, Khondker L, Khan SI. Comparative efficacy of methotrexate and mini pulse betamethasone in the treatment of lichen planus. Mymensingh Med J 2013;22:787-97.
20. Kanwar AJ, De D. Methotrexate for treatment of lichen planus: Old drug, new indication. J Eur Acad Dermatol Venereol 2013;27:e410-3.
21. Olsen EA, Whiting DA, Savin R, Rodgers A, Johnson-Levonas AO, Round E, et al. Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo. J Am Acad Dermatol 2012;67:379-86.
22. Donati A, Assouly P, Matard B, Jouanique C, Reygagne P. Clinical and photographic assessment of lichen planopilaris treatment efficacy. J Am Acad Dermatol 2011;64:597-8.
23. Rácz E, Gho C, Moorman PW, Noordhoek Hegt V, Neumann HA. Treatment of frontal fibrosing alopecia and lichen planopilaris: A systematic review. J Eur Acad Dermatol Venereol 2013;27:1461-70.
24. Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate: Implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Jt Dis 2007;65:168-73.
25. Brown PM, Pratt AG, Isaacs JD. Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. Nat Rev Rheumatol 2016;12:731-42.